News | Radiation Oncology | August 30, 2023

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden 

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden

Dr. Laurent Leksell, Elekta’s Founder and Chairman of the Board, and IAEA’s Director General, Dr. Rafael Mariano Grossi meet in Stockholm to discuss reducing the global cancer burden. Image courtesy of IAEA 


August 30, 2023 — Elekta and the IAEA have signed a partnership agreement to jointly pursue common interests, including making advanced cancer treatment available to more patients. The agreement was signed on Monday, August 28 at Elekta’s headquarters in Stockholm during a three-day visit to Sweden by Dr. Grossi and IAEA representatives. 

The purpose of this partnership is to improve cancer treatment with the intent to close the gap in access to radiation therapy around the world. This closer collaboration will enable a continuous dialogue and knowledge sharing in the coordination and implementation of joint efforts. Specifically, it will address low- and middle-income countries and include awareness raising activities, the development of training resources, as well as the use of digital tools to improve treatment quality and facilitate research. 

The organizations share a common vision with the IAEA’s Rays of Hope program and Elekta’s ACCESS 2025 strategy. Each of these supports the UN’s Sustainable Development Goal 3 (Good Health and Well-Being), Indicator 3.4, to reduce premature mortality from non-communicable diseases by one third. 

Dr. Laurent Leksell said: “Close to 20 million people are diagnosed with cancer each year and this is expected to increase. Elekta and the IAEA have had a long-standing relationship committed to reducing this grim statistic by enhancing access to cancer care in developing countries. Together, we will be able accelerate our efforts and make a greater impact on the lives of people with cancer, especially in underserved countries.” 

Dr. Rafael Mariano Grossi added: “We must all work together to tackle a growing cancer burden around the world, especially in developing countries with little or no access to essential medical services required for this disease. Under its Rays of Hope initiative, the IAEA is intensifying its activities to bring cancer care to those that need it the most. Joining forces with key stakeholders in both the public and private sectors will help leverage our efforts and save countless lives. I am very proud that the IAEA is collaborating with Elekta in our shared aim to improve access to radiotherapy in countries where it is urgently needed.” 

Under the new partnership agreement, Elekta and the IAEA are seeking to expand previous cooperation, which, to date, has included the facilitation of training as well as the provision of radiation therapy solutions, such as linear accelerators, brachytherapy treatment equipment, treatment planning workstations and related software, in several IAEA Member States. 

For more information: www.elekta.com


Related Content

News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
News | Radiology Business

July 31, 2024 — The American Registry of Radiologic Technologists (ARRT) announced the three Registered Technologists (R ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 24, 2024 — Telix Pharmaceuticals Limited announced that the United States (U.S.) Food and Drug Administration (FDA) ...

Time July 24, 2024
arrow
News | Radiation Therapy

July 22, 2024 — RefleXion Medical, an external-beam theranostic oncology company, today announced that researchers from ...

Time July 22, 2024
arrow
News | ASTRO

July 18, 2024 — The members of the American Society for Radiation Oncology (ASTRO) recently elected five new officers to ...

Time July 18, 2024
arrow
News | PET-CT

July 16, 2024 — A new research paper was published in Oncotarget's Volume 15 on June 20, 2024, titled, “Comparison of ...

Time July 16, 2024
arrow
News | Digital Pathology

July 12, 2024 — AGFA HealthCare, a global leader in healthcare imaging management solutions, announced that Enterprise ...

Time July 12, 2024
arrow
News | Digital Pathology

July 12, 2024 — Diagnosing cancer and providing the personalized therapy it often requires, is a collaborative effort ...

Time July 12, 2024
arrow
Subscribe Now